Cargando…

Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses

Seasonal influenza vaccines provide protection against matching influenza A virus (IAV) strains mainly through the induction of neutralizing serum IgG antibodies. However, these antibodies fail to confer a protective effect against mismatched IAV. This lack of efficacy against heterologous influenza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soema, Peter Christiaan, van Riet, Elly, Kersten, Gideon, Amorij, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432795/ https://www.ncbi.nlm.nih.gov/pubmed/26029218 http://dx.doi.org/10.3389/fimmu.2015.00237

Ejemplares similares

Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses
por: Soema, Peter C., et al.
Publicado: (2014)

Developments in the formulation and delivery of spray dried vaccines
por: Kanojia, Gaurav, et al.
Publicado: (2017)

Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
por: Soema, Peter C., et al.
Publicado: (2014)

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8(+) T Cell Epitopes
por: Soema, Peter C., et al.
Publicado: (2018)

Development of Thermostable Lyophilized Inactivated Polio Vaccine
por: Kraan, Heleen, et al.
Publicado: (2014)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Buccal and sublingual vaccine delivery
por: Kraan, Heleen, et al.
Publicado: (2014)

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
por: van der Ley, Peter A., et al.
Publicado: (2021)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine
por: Kraan, Heleen, et al.
Publicado: (2016)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
por: Raeven, René H. M., et al.
Publicado: (2019)

Systems vaccinology and big data in the vaccine development chain
por: Raeven, René H. M., et al.
Publicado: (2018)

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
por: Choi, Angela, et al.
Publicado: (2020)

Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch
por: Zhu, Wandi, et al.
Publicado: (2018)

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
por: Christensen, Dennis, et al.
Publicado: (2018)

Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin
por: Grødeland, Gunnveig, et al.
Publicado: (2020)

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
por: Rosendahl Huber, Sietske K., et al.
Publicado: (2019)

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization
por: Bhide, Yoshita, et al.
Publicado: (2019)

Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus
por: Gautam, Avishekh, et al.
Publicado: (2019)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

ADCC: An underappreciated correlate of cross-protection against influenza?
por: de Vries, Rory D., et al.
Publicado: (2023)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

Advances in Development and Application of Influenza Vaccines
por: Chen, Jidang, et al.
Publicado: (2021)

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
por: Thomson, C. A., et al.
Publicado: (2012)

Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
por: Carascal, Mark B., et al.
Publicado: (2022)

Pan-Influenza A Protection by Prime–Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model
por: Jang, Yo Han, et al.
Publicado: (2018)

Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses
por: Raeven, René H. M., et al.
Publicado: (2020)

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
por: Covián, Camila, et al.
Publicado: (2019)

Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
por: Carascal, Mark B., et al.
Publicado: (2022)

Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
por: Li, Mengling, et al.
Publicado: (2021)

Influenza and Antibody-Dependent Cellular Cytotoxicity
por: Von Holle, Tarra A., et al.
Publicado: (2019)

Radiation-Inactivated S. gallinarum Vaccine Provides a High Protective Immune Response by Activating Both Humoral and Cellular Immunity
por: Ji, Hyun Jung, et al.
Publicado: (2021)

cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model
por: Vassilieva, Elena V., et al.
Publicado: (2021)

Measurement of Cellular Immune Response to Viral Infection and Vaccination
por: Bouwman, Wilbert, et al.
Publicado: (2020)

Novel Platforms for the Development of a Universal Influenza Vaccine
por: Kumar, Arun, et al.
Publicado: (2018)

OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza
por: Del Campo, Judith, et al.
Publicado: (2021)

Influenza B: Prospects for the Development of Cross-Protective Vaccines
por: Tsybalova, Liudmila M., et al.
Publicado: (2022)

Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
por: Vermaelen, Karim
Publicado: (2019)

Characterization of the early cellular immune response induced by HPV vaccines
por: Pasmans, Hella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ucnn37engav2dehjutu44ol26c